Nagano, Japan

Masahiko Uchida

This inventor holds 5 USPTO granted patents. Top assignee: Kissei Pharmaceutical Co., Ltd.. Active years: 1994-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masahiko Uchida. Retrieved from https://idiyas.com/inventor/masahiko-uchida

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 20.0

Average Co-Inventor Count = 8.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1994-2009

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Masahiko Uchida: Innovator in Pharmaceutical Chemistry

Introduction

Masahiko Uchida is a prominent inventor based in Nagano, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 5 patents. His work focuses on innovative compounds that have the potential to impact medical treatments.

Latest Patents

Uchida's latest patents include the development of 5-amidino-2-hydroxybenzenesulfonamide derivatives. These compounds are designed for use in pharmaceutical compositions and include intermediates for their preparation. The invention relates to a derivative represented by a specific general formula, where R can be a hydrogen atom or an optionally substituted lower alkyl group.

Career Highlights

Masahiko Uchida has established himself as a key figure in the pharmaceutical industry through his work at Kissei Pharmaceutical Co., Ltd. His innovative approach to drug development has led to advancements in therapeutic options available to patients.

Collaborations

Uchida has collaborated with notable colleagues, including Kosuke Okazaki and Hiroaki Kobayashi. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Masahiko Uchida's contributions to pharmaceutical chemistry exemplify the importance of innovation in medical science. His patents and collaborative efforts continue to pave the way for new therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…